MAPT and Alzheimer disease: Changes in glycosylation pattern of key AD-related molecules such as APP, Tau, BACE1, and APOE have previously been identified (Vanoni et al., 2008; Kizuka et al., 2016, 2017; Flowers et al., 2020; Losev et al., 2020).